Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism
about
Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health StudyEvolution of the arginase fold and functional diversityNeurological implications of urea cycle disordersClinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiencyPhase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.Amino acid supplementation affects imprinted gene transcription patterns in parthenogenetic porcine blastocysts.Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes.Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond.Requirement of argininosuccinate lyase for systemic nitric oxide production.Contrasting features of urea cycle disorders in human patients and knockout mouse models.Lysine 88 acetylation negatively regulates ornithine carbamoyltransferase activity in response to nutrient signals.Polar bears exhibit genome-wide signatures of bioenergetic adaptation to life in the arctic environmentConcise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic DefectsOrnithine transcarbamylase deficiency: a possible risk factor for thrombosis.Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism
P2860
Q24293230-2D9DCA4C-E93C-4487-9E40-29E54D65F06DQ24642568-1CE18B47-F6BE-4430-908E-3C1788A1D226Q31137640-709B0084-F8E6-4F53-968B-C6FC448DC44BQ33737998-26CBFE8C-FF31-423B-9C42-C67EEAF3BDACQ34000081-AB52BAF4-3D04-4152-A47E-A7A2AC11D320Q34122707-17612004-8AD8-497B-914E-2DA502C79E5DQ34162466-4DE97E14-B74C-4FA0-AC48-933DC397225EQ34222287-38A54280-8E93-4A64-B8E2-9020C87AE7ABQ34775132-DA4D8F60-3215-410C-85B2-A68FD5895380Q35948795-A84F0BB7-E4DB-4276-899B-6647976B3B98Q36969510-0849B552-0377-47F3-8064-E62AF43CC41CQ37185284-2EE2BB67-8E11-4CA9-B82A-2E00F82F1278Q37616522-A1E3508E-C894-41A1-B3DF-BE415AFAE4AAQ38849210-889B5E2F-28CA-47E8-93FA-D36E415F9E10Q42016529-3231F9F2-EE23-44FD-86A3-2DCABD764FB0Q42736725-73C1DF79-1C76-428D-A2D7-75CC672962DE
P2860
Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Clinical consequences of urea ...... ne and nitric oxide metabolism
@ast
Clinical consequences of urea ...... ne and nitric oxide metabolism
@en
Clinical consequences of urea ...... ne and nitric oxide metabolism
@nl
type
label
Clinical consequences of urea ...... ne and nitric oxide metabolism
@ast
Clinical consequences of urea ...... ne and nitric oxide metabolism
@en
Clinical consequences of urea ...... ne and nitric oxide metabolism
@nl
prefLabel
Clinical consequences of urea ...... ne and nitric oxide metabolism
@ast
Clinical consequences of urea ...... ne and nitric oxide metabolism
@en
Clinical consequences of urea ...... ne and nitric oxide metabolism
@nl
P2093
P356
P1433
P1476
Clinical consequences of urea ...... ne and nitric oxide metabolism
@en
P2093
Brendan Lee
Farook Jahoor
Fernando Scaglia
Juan Marini
Nicola Brunetti-Pierri
Peter Garlick
Soledad Kleppe
Susan Carter
William O'Brien
P304
2775S-2782S; discussion 2796S-2797S
P356
10.1093/JN/134.10.2775S
P407
P433
P577
2004-10-01T00:00:00Z